Molecular, Cellular, and developmental biology
Gregory LaRosa, Ph.D., is a proven leader and builder of discovery research and translation organizations in both small and large biopharmaceutical companies. He is the president of GL BioConsulting, which focuses on small molecules, antibody/protein, and gene therapy therapeutic candidate discovery and early clinical development.
Experience
- More than 30 years in the biopharmaceutical space delivering multiple candidates to clinical development in the areas of rare genetic disease and inflammation
- Served as Vice President and Head of Scientific Research of Pfizer’s Rare Disease Research Unit
- Was the interim Chief Scientific Officer for several years and the Head of Biology for Pfizer’s Rare Disease Research Unit, responsible for scientific strategies, including evaluation of external opportunities and oversight of the pre-clinical and early clinical project progression
Expertise
- Working with companies ranging from startups to major international corporations in the areas of rare genetic diseases, inflammation, and chemokine biology
- Molecular, cellular, and developmental biology
- Developing strategy and driving research forward